Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Dan Hurley, M.D. Endowment Fund for Insurance Authorizations

    Daniel Brian Hurley, M.D. passed away August 3, 2023, from dedifferentiated chondrosarcoma at age 50 surrounded by his loved ones. His wife Traci and their three kids Rachel, Sam, and Sarah were the light of his life. His family, including his...

    Read Article

    Call for Action

    Be Part of the First full Analysis of the Chondrosarcoma Patient Registry https://chondrosarcoma.iamrare.org It is not too late to sign up to participate in the Chondrosarcoma Patient Registry. The Chondrosarcoma Foundation has been preparing to...

    Read Article

    Thank You for Supporting Chondrosarcoma Awareness Day

    Thank You!!!! To Everyone that participated in Chondrosarcoma Awareness Day. It is wonderful to see people from all over the globe come together to honor our CS survivors and those who lost their battle to this terrible bone cancer. And it is great...

    Read Article

    Final Tribute and Introduction of the Daniel B. Hurley, M.D. Endowment Fund

    Tomorrow, February 6 is Chondrsarcoma Awareness Day. Join the Fight Wear something Yellow. Take a picture (family, friends, work colleagues) and post it to #cswecare #chondrosarcoma #chondrosarcomafoundation Sign our Petition to support more...

    Read Article

    Tuesday February 6 is Chondrosarcoma Awareness Day.

    This coming Tuesday, February 6 is Chondrsarcoma Awareness Day. Join the Fight Wear something Yellow. Take a picture (family, friends, work colleagues) and post it to #cswecare #chondrosarcoma #chondrosarcomafoundation Sign our Petition to...

    Read Article

    Preclinical Characterization and Phase I Trial Results,of INBRX-109, A Third-Generation, Recombinant,,Humanized, Death Receptor 5 Agonist Antibody,,in Chondrosarcoma

    Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma Vivek Subbiah1, Sant P. Chawla2, Anthony P. Conley3, Breelyn A. Wilky4, Anthony...

    Read Article

    Nicole fights for our Country while fighting her own battle with Extraskeletal Myxoid Chondrosarcoma

    Sixth Tribute for Chondrosarcoma Awareness Day NIne Days away from hosting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 33rd birthday). This is our international effort to educate the public about this rare bone cancer and to...

    Read Article

    Brenda Segelken, shares her story of Chondrosarcoma

    Fourth Tribute for Chondrosarcoma Awareness Day Two weeks away from hosting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 33rd birthday). This is our international effort to educate the public about this rare bone cancer and to...

    Read Article